Last reviewed · How we verify

NCT05416918

Clinical Value of Metagenomic Sequencing in Neonatal Sepsis

Completed Last updated 28 December 2023
What this trial tests

trial in Neonatal Sepsis in 200 participants. Completed in 30 December 2022.

Timeline
1 April 2022
Primary endpoint
1 December 2022
30 December 2022

Quick facts

Lead sponsorChildren's Hospital of Fudan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment200
Start date1 April 2022
Primary completion1 December 2022
Estimated completion30 December 2022
Sites1 location across China

Conditions studied

Sponsor

Children's Hospital of Fudan University

Who can join

Adults 0 Days to 28 Days, any sex, with Neonatal Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to enroll 2000 neonatal patients with suspected sepsis or clinical diagnosed sepsis. These patients will undergo both conventional methods and metagenomics sequencing to detect the pathogenic microorganisms of sepsis. The purpose of this study was to assess the clinical value of metagenomics sequencing for the diagnosis and treatment of neonatal sepsis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Molecular assays for the diagnosis of sepsis in neonates: a diagnostic test accuracy review.
    Dierikx TH, Visser DH, de Meij T, Versalovic J, et al · · 2025 · cited 3× · PMID 40105375 · DOI 10.1002/14651858.cd011926.pub3

Verify or expand the search:

Other recruiting trials for Neonatal Sepsis

Currently open trials in the same condition.

Other Children's Hospital of Fudan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05416918.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing